Broad Institute Receives $650 Million Gift for Psychiatric Research
the Psychiatry Advisor take:
The largest private donation for psychiatric research — $650 million — has been given to the Cambridge, Massachusetts-based Broad Institute by philanthropist and businessman Ted Stanley.
Stanley, who made his fortune heading a company that markets and sells collectibles, was moved to support mental health research after his son, Jonathan, was diagnosed with bipolar disorder in college. He was treated with lithium and is now a successful lawyer.
“Essentially, it gave him the ability to have a normal life with a normal functioning brain,” Stanley told The Boston Globe. “If I had had the same downfall at the same age that he had, I would have had my life ruined . . . because in between when I was that age and he was that age, someone had discovered that lithium makes people well when they have that illness.”
The Stanley Medical Research Institute had previously given the Broad a $175 million gift. The $650 million gift will not be given at once, but in annual payments with more after Stanley’s death.
Broad researchers contributed to the recent publication in Nature of the largest genomic study of schizophrenia. That study could lead to new treatments that target the molecular causes of the disease.
Philanthropist Gives $650 Million Gift for Psychiatric Research
Sign Up for Free e-newsletters
Psychiatry Advisor Articles
- Hospitalization Rates in Schizophrenia—Lurasidone vs Quetiapine
- Psychopathology of Adults Affected by Pre- and Perinatal Factors, Family Functioning
- Family History of Psychiatric Disorders an Important Predictor of Postpartum Psychiatric Illness
- Anxiety: Feature of Late-Onset Dementia or Modifiable Risk Factor?
- New APA President Takes Office as the First African-American to Lead the Organization
- Video Games and Exercise as Alternative Therapies for ADHD
- How Parents Can Enhance Autism Treatment: Use of Intervention Strategies at Home
- Electroconvulsive Therapy Effective in Children With Autism
- The Cutting Edge of Schizophrenia Research: VR as Treatment for Psychosis
- Comorbid Autism Spectrum Disorder and OCD: Challenges in Diagnosis and Treatment
- New Dimensions in Psychopathy: Are There Cultural Differences in Psychopaths?
- Addressing Psychiatric Comorbidities in Inflammatory Rheumatic Diseases
- Exploring the Link Between Persistent Infection, Inflammation, and Mood Disorders
- CDC: No Change in Level of Uninsured in US in 2017
- Benefit of Behavioral Activation During TMS for Major Depressive Disorder